A previous study demonstrated increased GR expression in tumors from PCa patients treated with neoadjuvant chemotherapy and observed GR overexpression in the DTX-resistant cell lines PC3-DR, DU145-DR, and 22rv1-DR [22]. The gene discussed is NR3C1; the disease is posterior cortical atrophy.